IL1B and metabolic dysfunction-associated steatohepatitis: The results showed reduced mRNA levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in the liver of the NASH mice, indicating the therapeutic potential of QRQZ on NASH [64].